Proton pump inhibitor use linked to C. diff AstraZeneca introduces Nexium 'smart card'AstraZeneca Canada Inc. has introduced a support program designed to take cost out of the equation in the patient’s choice between Nexium tablets and a generic esomeprazole product. References: Managing chemotherapy side effects Cancer care in the community: the drugstore's role. Clinical Notes: PPI efficacy and safety in children with GERD PPIs not effective in reducing gastroesophageal reflux disease symptoms in infants, study finds. ABCs of OTCs CE event puts focus on nonprescription products. Eosinophilic Esophagitis Eosinophilic esophagitis (EE) has emerged as a “new” inflammatory condition of note, one that has been diagnosed with increased frequency in both children and adults throughout the world. Reflux: ‘It’s just a bit of heartburn’ — or is it? Condition is often not as well-controlled as we would like to think Gastric bypass patients gone bad Long-term PPI use may cause serious hypomagnesemia U.S. FDA communicating safety concerns regarding potential development of hypomagnesemia when PPIs taken for prolonged periods. Self-Care & Wellness: Help the Burn The OTC management of GERD. First Previous 9 10 11 12 13 Next Last
